BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11985951)

  • 1. Obesity, metabolic syndrome X, and inflammation.
    Das UN
    Nutrition; 2002 May; 18(5):430-2. PubMed ID: 11985951
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin resistance: a genetic approach. Overview.
    Martínez Larrad MT; González Sánchez JL; Serrano Ríos M
    Nestle Nutr Workshop Ser Clin Perform Programme; 2002; 6():79-93; discussion 93-5. PubMed ID: 16969968
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links.
    Zafar U; Khaliq S; Ahmad HU; Manzoor S; Lone KP
    Hormones (Athens); 2018 Sep; 17(3):299-313. PubMed ID: 30171523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
    Sveklina TS; Talantseva MS; Barsukov AV
    Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders.
    Hong CP; Yun CH; Lee GW; Park A; Kim YM; Jang MH
    Obesity (Silver Spring); 2015 Nov; 23(11):2199-206. PubMed ID: 26260403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.
    Vlassara H; Cai W; Tripp E; Pyzik R; Yee K; Goldberg L; Tansman L; Chen X; Mani V; Fayad ZA; Nadkarni GN; Striker GE; He JC; Uribarri J
    Diabetologia; 2016 Oct; 59(10):2181-92. PubMed ID: 27468708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity.
    Chen Z; Shen H; Sun C; Yin L; Tang F; Zheng P; Liu Y; Brink R; Rui L
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E460-9. PubMed ID: 25628422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome.
    Koren D; Taveras EM
    Metabolism; 2018 Jul; 84():67-75. PubMed ID: 29630921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue and the insulin resistance syndrome.
    Frayn KN
    Proc Nutr Soc; 2001 Aug; 60(3):375-80. PubMed ID: 11681812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory components of adipose tissue as target for treatment of metabolic syndrome.
    Yu R; Kim CS; Kang JH
    Forum Nutr; 2009; 61():95-103. PubMed ID: 19367114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is metabolic syndrome X an inflammatory condition?
    Das UN
    Exp Biol Med (Maywood); 2002 Dec; 227(11):989-97. PubMed ID: 12486208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and the metabolic syndrome.
    Lann D; Gallagher E; Leroith D
    Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetuin-A is also an adipokine.
    Jialal I; Pahwa R
    Lipids Health Dis; 2019 Mar; 18(1):73. PubMed ID: 30917813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity.
    de Luis DA; Izaola O; de la Fuente B; Primo D; Aller R
    J Nutrigenet Nutrigenomics; 2016; 9(5-6):213-221. PubMed ID: 27788523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice.
    Lancaster GI; Kraakman MJ; Kammoun HL; Langley KG; Estevez E; Banerjee A; Grumont RJ; Febbraio MA; Gerondakis S
    PLoS One; 2014; 9(11):e111524. PubMed ID: 25375135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of Trp64Arg polymorphism of beta 3 adrenoreceptor gene with metabolic syndrome and insulin resistance in obese women.
    De Luis Román DA; Primo D; Izaola O; Aller R
    Nutr Hosp; 2017 Mar; 34(2):383-388. PubMed ID: 28421794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice].
    León-Pedroza JI; González-Tapia LA; del Olmo-Gil E; Castellanos-Rodríguez D; Escobedo G; González-Chávez A
    Cir Cir; 2015; 83(6):543-51. PubMed ID: 26159364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rs1501299 Polymorphism in the Adiponectin Gene and Their Association with Total Adiponectin Levels, Insulin Resistance and Metabolic Syndrome in Obese Subjects.
    de Luis DA; Izaola O; de la Fuente B; Primo D; Fernandez Ovalle H; Romero E
    Ann Nutr Metab; 2016; 69(3-4):226-231. PubMed ID: 27915341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is obesity an adaptative response to inflammation?
    Ailhaud G
    Obes Rev; 2012 May; 13(5):480-1. PubMed ID: 22500727
    [No Abstract]   [Full Text] [Related]  

  • 20. AMPK/Mitochondria in Metabolic Diseases.
    Bullon P; Marin-Aguilar F; Roman-Malo L
    Exp Suppl; 2016; 107():129-152. PubMed ID: 27812979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.